DAILY-STOP

European agency finds AstraZeneca can cause rare blood clots, but benefits outweigh risks

The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.

Share:

Leave a Reply Cancel reply

Categories

Related Posts

What to Expect from a Potential Trump Administration in 2025

As Donald Trump campaigns for a potential return to the presidency, speculation grows about what his administration might prioritize and how it would shape the

Top Investments for 2025: A Focus on the S&P 500

As we move into 2025, the S&P 500 continues to be a cornerstone of investment strategies, offering insights into the U.S. stock market’s health. Following

Top Lifestyle Trends for 2025: What’s Shaping the Future of How We Live

As we step into 2025, the world is witnessing a rapidly evolving landscape of lifestyle choices and trends. With technology advancing at an unprecedented pace,

Must-Have Lifestyle Items in 2024

As we embrace 2024, staying ahead of the curve in lifestyle trends is key to enhancing our day-to-day living. From tech gadgets to home essentials,